Skip to content

Natixis Investment Managers: XYL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Natixis Investment Managers on XYL, newest first. How the timeline and the estimate are built.

Natixis Investment Managers held 2,041,728 XYL shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,041,728 shares
    Change vs previous 13F -154,720 shares

    0.2% of the 13F portfolio, value $241,351,946.

    13F-HR 0001172661-26-003465 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 71,396 shares
    • NATIXIS: 9,302 shares
    • MIROVA: 253,836 shares
    • Mirova US LLC: 1,707,194 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,196,448 shares
    Change vs previous 13F -144,479 shares

    0.24% of the 13F portfolio, value $262,475,132.

    13F-HR 0001172661-26-001659 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 72,631 shares
    • NATIXIS: 71,864 shares
    • MIROVA: 244,505 shares
    • Mirova US LLC: 1,807,448 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,340,927 shares
    Change vs previous 13F -159,828 shares

    0.3% of the 13F portfolio, value $318,787,564.

    13F-HR 0001172661-26-000622 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 275,928 shares
    • NATIXIS: 31,583 shares
    • MIROVA: 152,226 shares
    • Mirova US LLC: 1,881,190 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,500,755 shares
    Change vs previous 13F -66,249 shares

    0.38% of the 13F portfolio, value $368,861,445.

    13F-HR 0001172661-25-004335 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 377,213 shares
    • NATIXIS: 38,198 shares
    • MIROVA: 152,210 shares
    • Mirova US LLC: 1,933,134 shares

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,567,004 shares
    Change vs previous 13F +242,214 shares

    0.36% of the 13F portfolio, value $332,067,694.

    13F-HR 0001172661-25-002691 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 393,135 shares
    • NATIXIS: 29,102 shares
    • MIROVA: 144,268 shares
    • Mirova US LLC: 2,000,499 shares

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F/A 2,324,790 shares
    Change vs previous 13F +304,923 shares

    0.44% of the 13F portfolio, value $277,719,095.

    13F-HR 0001172661-25-002088 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 332,298 shares
    • NATIXIS: 0 shares
    • MIROVA: 86,221 shares
    • Mirova US LLC: 1,906,271 shares

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,019,867 shares
    Change vs previous 13F -50,541 shares

    0.3% of the 13F portfolio, value $234,345,204.

    13F-HR 0001172661-25-000614 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 87,888 shares
    • NATIXIS: 6,381 shares
    • MIROVA: 83,983 shares
    • Mirova US LLC: 1,841,615 shares

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 2,070,408 shares
    Change vs previous 13F not available

    0.46% of the 13F portfolio, value $279,567,052.

    13F-HR 0001172661-24-004985 filed by Mirova US LLC
    Filed (acceptance time not in the bulk data set), ingested

    • NATIXIS ADVISORS, LLC: 108,177 shares
    • NATIXIS: 0 shares
    • MIROVA: 66,065 shares
    • Mirova US LLC: 1,896,166 shares

    Acceptance time not in the bulk data set (spec §4.2).